238 related articles for article (PubMed ID: 36578072)
1. SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma.
Li Y; Gao Y; Jiang X; Cheng Y; Zhang J; Xu L; Liu X; Huang Z; Xie C; Gong Y
J Transl Med; 2022 Dec; 20(1):628. PubMed ID: 36578072
[TBL] [Abstract][Full Text] [Related]
2. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
[TBL] [Abstract][Full Text] [Related]
3. SAMHD1 can suppress lung adenocarcinoma progression through the negative regulation of STING.
Wu Y; Niu Y; Wu Y; Chen X; Shen X; Gao W
J Thorac Dis; 2021 Jan; 13(1):189-201. PubMed ID: 33569199
[TBL] [Abstract][Full Text] [Related]
4. Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer.
Qiu J; Xia Y; Bao Y; Cheng J; Liu L; Qian D
J Transl Med; 2024 Mar; 22(1):228. PubMed ID: 38431575
[TBL] [Abstract][Full Text] [Related]
5. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma.
Cai Y; Chen X; Lu T; Fang X; Ding M; Yu Z; Hu S; Liu J; Zhou X; Wang X
Int J Biol Sci; 2023; 19(14):4627-4643. PubMed ID: 37781035
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation.
Xiong H; Xi Y; Yuan Z; Wang B; Hu S; Fang C; Cai Y; Fu X; Li L
Oncoimmunology; 2022; 11(1):2044103. PubMed ID: 35273829
[TBL] [Abstract][Full Text] [Related]
7. Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1.
Maelfait J; Bridgeman A; Benlahrech A; Cursi C; Rehwinkel J
Cell Rep; 2016 Aug; 16(6):1492-1501. PubMed ID: 27477283
[TBL] [Abstract][Full Text] [Related]
8. Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner.
Schumann T; Ramon SC; Schubert N; Mayo MA; Hega M; Maser KI; Ada SR; Sydow L; Hajikazemi M; Badstübner M; Müller P; Ge Y; Shakeri F; Buness A; Rupf B; Lienenklaus S; Utess B; Muhandes L; Haase M; Rupp L; Schmitz M; Gramberg T; Manel N; Hartmann G; Zillinger T; Kato H; Bauer S; Gerbaulet A; Paeschke K; Roers A; Behrendt R
J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36346347
[TBL] [Abstract][Full Text] [Related]
9. STING-mediated degradation of IFI16 negatively regulates apoptosis by inhibiting p53 phosphorylation at serine 392.
Li D; Xie L; Qiao Z; Mai S; Zhu J; Zhang F; Chen S; Li L; Shen F; Qin Y; Yao H; He S; Ma F
J Biol Chem; 2021 Aug; 297(2):100930. PubMed ID: 34216619
[TBL] [Abstract][Full Text] [Related]
10. Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses.
Iqbal J; Ansari MA; Kumar B; Dutta D; Roy A; Chikoti L; Pisano G; Dutta S; Vahedi S; Veettil MV; Chandran B
PLoS Pathog; 2016 Oct; 12(10):e1005967. PubMed ID: 27764250
[TBL] [Abstract][Full Text] [Related]
11. IFI16 Positively Regulates RIG-I-Mediated Type I Interferon Production in a STING-Independent Manner.
Shi X; Wei M; Feng Y; Yang Y; Zhang X; Chen H; Xing Y; Wang K; Wang W; Wang L; Wang A; Zhang G
DNA Cell Biol; 2024 Apr; 43(4):197-205. PubMed ID: 38466944
[TBL] [Abstract][Full Text] [Related]
12. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways.
Chen S; Bonifati S; Qin Z; St Gelais C; Kodigepalli KM; Barrett BS; Kim SH; Antonucci JM; Ladner KJ; Buzovetsky O; Knecht KM; Xiong Y; Yount JS; Guttridge DC; Santiago ML; Wu L
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3798-E3807. PubMed ID: 29610295
[TBL] [Abstract][Full Text] [Related]
13. The dNTPase activity of SAMHD1 is important for its suppression of innate immune responses in differentiated monocytic cells.
Qin Z; Bonifati S; St Gelais C; Li TW; Kim SH; Antonucci JM; Mahboubi B; Yount JS; Xiong Y; Kim B; Wu L
J Biol Chem; 2020 Feb; 295(6):1575-1586. PubMed ID: 31914403
[TBL] [Abstract][Full Text] [Related]
14. IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer.
Ka NL; Lim GY; Hwang S; Kim SS; Lee MO
Cell Rep; 2021 Dec; 37(12):110138. PubMed ID: 34936865
[TBL] [Abstract][Full Text] [Related]
15. Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.
Li L; Yang L; Cheng S; Fan Z; Shen Z; Xue W; Zheng Y; Li F; Wang D; Zhang K; Lian J; Wang D; Zhu Z; Zhao J; Zhang Y
Mol Cancer; 2019 Jun; 18(1):108. PubMed ID: 31221150
[TBL] [Abstract][Full Text] [Related]
16. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.
Dai X; Lu L; Deng S; Meng J; Wan C; Huang J; Sun Y; Hu Y; Wu B; Wu G; Lovell JF; Jin H; Yang K
Theranostics; 2020; 10(20):9332-9347. PubMed ID: 32802195
[No Abstract] [Full Text] [Related]
17. Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses.
Ansari MA; Dutta S; Veettil MV; Dutta D; Iqbal J; Kumar B; Roy A; Chikoti L; Singh VV; Chandran B
PLoS Pathog; 2015 Jul; 11(7):e1005019. PubMed ID: 26134128
[TBL] [Abstract][Full Text] [Related]
18. Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING.
Panchanathan R; Liu H; Xin D; Choubey D
Innate Immun; 2014 Oct; 20(7):751-9. PubMed ID: 24131791
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Might Be Sensed by STING-Dependent DNA Sensors and Attenuates the Response of STING-Dependent DNA Sensing Pathway in Humans with Acute and Chronic Hepatitis B Virus Infection.
Chen H; He G; Chen Y; Zhang X
Viral Immunol; 2020 Dec; 33(10):642-651. PubMed ID: 33170089
[TBL] [Abstract][Full Text] [Related]
20. PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer.
Zhang N; Gao Y; Zeng Z; Luo Y; Jiang X; Zhang J; Li J; Zhang J; Gong Y; Xie C
Clin Transl Oncol; 2021 Sep; 23(9):1827-1837. PubMed ID: 33774805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
